Bluebird Bio Inc. BLUE stock price is finally showing some life as it reverses trend. BLUE is up 17% in the last month and I will be evaluating many factors to determine just how hot the stock is.
The official heat level for BLUE is, a 🔥🔥 2 out of 5.
Continue reading to see why I think it is just a 2 out of 5. There is some shocking takeaways from this article that you must read if you are interested in BLUE.
If you are interested in finding out more about me, famed stock picker, Alexander Goldman or if you’re interested in my HOT grading system, sign up today, it’s FREE!
👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇 In fact, I will send you personally a 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter.
[thrive_leads id=’14274′]
Before I go over this exciting trending stock, I wanted to introduce myself. Hello 🙋♂️ My name is Alexander Goldman. I have been trading, at a very high level, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT grading system for trending stocks.
I found my home at Small Cap exclusive 4 years ago. Now, I’m helping traders find breakout stocks. Not to sound egotistical but I’m very good at finding small cap stocks that are winners.
What do I mean by big winners?
Stocks that move more than 100% in a month! BLUE Stock Price could?
Does that always happen, NO! But, I’m very consistent! Take a look at this article I wrote below, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!
The article is HERE and I shine a spotlight on these breakout stocks and also those losers!
Now, let’s go over some of the basic information on this stock before we get in the technical analysis and how I came up with HOT grade.
Bluebird Bio Inc. Company Information
Company Name: Bluebird Bio Inc.
Ticker: BLUE
Exchange: NASDAQ
Website: https://www.bluebirdbio.com/
Breakout Stock Bluebird Bio Company Summary:
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
BLUE stock price is due to News?
June 10th
Announced the outcome of the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) discussion of elivaldogene autotemcel (eli-cel) for the treatment of early active cerebral adrenoleukodystrophy (CALD) in patients less than 18 years of age who do not have an available and willing human leukocyte antigen (HLA)-matched sibling hematopoietic stem cell (HSC) donor.
Trending Stock BLUE 5 Day Chart
BLUE Stock Price HOT Stock Grade:
The official heat level for BLUE is, a 🔥🔥 2 out of 5 . Continue reading to see why I think it is just a 2 out of 5. Here are my takeaways on SMCE and why it is just a 2 out of 5.
The volume, which is basically demand of a stock is sporadic and has a downward pressure on it.
The news, there is no significant news cycle circulating around BLUE stock price.
The chart, it is bearish and has been that way for a while.
The fundamentals, there is no exciting financial filings associated with this stock.
Marketing efforts, I have found marketing efforts around the investor awareness of this company which saved it from a 1 out of 5 rating.
To receive my 🔥🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.
👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇
[thrive_leads id=’14274′]
